Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL2334586 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
phosphoinositide kinase, FYVE-type zinc finger containing/1-phosphatidylinositol 3-phosphate 5-kinase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1938222] [GtoPdb: 2857] [UniProtKB: Q9Y2I7] | ||||||||
ChEMBL | Inhibition of PIKFYVE in HEK293 cells by NanoBRET assay | B | 7.85 | pIC50 | 14.1 | nM | IC50 | J Med Chem (2022) 65: 12860-12882 [PMID:36111834] |
ChEMBL | Inhibition of human wild type partial length PIKfyve (F1512 to C2098 residues) expressed in mammalian expression system by Kinomescan assay | B | 8.66 | pIC50 | 2.2 | nM | IC50 | J Med Chem (2022) 65: 12860-12882 [PMID:36111834] |
ChEMBL | Inhibition of human GST tagged PIKFYVE (1493 to end residues) expressed in baculovirus-infected Sf9 cells using PI(3)P:PS as substrate incubated for 60 mins in presence of ATP by ADP-Glo assay | B | 8.66 | pIC50 | 2.2 | nM | IC50 | J Med Chem (2022) 65: 12860-12882 [PMID:36111834] |
GtoPdb | - | - | 8.66 | pIC50 | 2.2 | nM | IC50 | J Med Chem (2022) 65: 12860-12882 [PMID:36111834] |
mitogen-activated protein kinase kinase kinase 14/Mitogen-activated protein kinase kinase kinase 14 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5888] [GtoPdb: 2074] [UniProtKB: Q99558] | ||||||||
GtoPdb | Enzymatic inhibition determined in a homogenous time resolved fluorescence (HTRF) assay for NIK (MAP3K14) | - | 6 | pKi | <1000 | nM | Ki | WO2009158011A1. Alkynyl alcohols as kinase inhibitors (2009) |
ChEMBL | Inhibition of NIK (unknown origin) | B | 6.5 | pIC50 | 316 | nM | IC50 | J Med Chem (2021) 64: 6358-6380 [PMID:33944571] |
ChEMBL | Inhibition of NIK in human HT-29 cells assessed as LTalpha/beta2-induced p100 processing to NFkappaB2 preincubated for 30 mins before LTalpha/beta2 stimulation measured after 5 hrs | B | 6.77 | pIC50 | 170 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 1238-1244 [PMID:23374866] |
ChEMBL | Inhibition of NIK (unknown origin) autophosphorylation after 1 hr by chemiluminescent assay | B | 7.39 | pIC50 | 41 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 1238-1244 [PMID:23374866] |
p21 (RAC1) activated kinase 4/Serine/threonine-protein kinase PAK 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4482] [GtoPdb: 2136] [UniProtKB: O96013] | ||||||||
ChEMBL | Inhibition of human wild type partial length PAK4 (Q144 to R438 residues) expressed in bacterial expression system by Kinomescan assay | B | 6.96 | pIC50 | 110 | nM | IC50 | J Med Chem (2022) 65: 12860-12882 [PMID:36111834] |
GtoPdb | - | - | 6.96 | pIC50 | 110 | nM | IC50 | J Med Chem (2022) 65: 12860-12882 [PMID:36111834] |
p21 (RAC1) activated kinase 6/Serine/threonine-protein kinase PAK6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4311] [GtoPdb: 2137] [UniProtKB: Q9NQU5] | ||||||||
GtoPdb | - | - | 7.22 | pIC50 | 60 | nM | IC50 | J Med Chem (2022) 65: 12860-12882 [PMID:36111834] |
ChEMBL | Inhibition of human wild type partial length PAK6 (N298 to C681 residues) expressed in bacterial expression system by Kinomescan assay | B | 7.22 | pIC50 | 60 | nM | IC50 | J Med Chem (2022) 65: 12860-12882 [PMID:36111834] |
p21 (RAC1) activated kinase 5/Serine/threonine-protein kinase PAK7 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4524] [GtoPdb: 2138] [UniProtKB: Q9P286] | ||||||||
ChEMBL | Inhibition of human wild type partial length PAK5 (Y400 to H719 residues) expressed in bacterial expression system by Kinomescan assay | B | 7.02 | pIC50 | 96 | nM | IC50 | J Med Chem (2022) 65: 12860-12882 [PMID:36111834] |
GtoPdb | - | - | 7.02 | pIC50 | 96 | nM | IC50 | J Med Chem (2022) 65: 12860-12882 [PMID:36111834] |
protein kinase X-linked/Serine/threonine-protein kinase PRKX in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5818] [GtoPdb: 2175] [UniProtKB: P51817] | ||||||||
ChEMBL | Inhibition of human wild type partial length PRKX (M1 to F358 residues) expressed in bacterial expression system by Kinomescan assay | B | 6.24 | pIC50 | 580 | nM | IC50 | J Med Chem (2022) 65: 12860-12882 [PMID:36111834] |
TAO kinase 1/Serine/threonine-protein kinase TAO1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5261] [GtoPdb: 2233] [UniProtKB: Q7L7X3] | ||||||||
ChEMBL | Inhibition of human wild type TAOK1 (M1 to A320 residues) expressed in mammalian expression system by Kinomescan assay | B | 7.7 | pIC50 | 20 | nM | IC50 | J Med Chem (2022) 65: 12860-12882 [PMID:36111834] |
GtoPdb | - | - | 7.7 | pIC50 | 20 | nM | IC50 | J Med Chem (2022) 65: 12860-12882 [PMID:36111834] |
TAO kinase 2/Serine/threonine-protein kinase TAO2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075195] [GtoPdb: 2234] [UniProtKB: Q9UL54] | ||||||||
GtoPdb | - | - | 7.04 | pIC50 | 91 | nM | IC50 | J Med Chem (2022) 65: 12860-12882 [PMID:36111834] |
ChEMBL | Inhibition of human wild type partial length TAOK2 (M1 to A320 residues) expressed in mammalian expression system by Kinomescan assay | B | 7.05 | pIC50 | 89 | nM | IC50 | J Med Chem (2022) 65: 12860-12882 [PMID:36111834] |
TAO kinase 3/Serine/threonine-protein kinase TAO3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5701] [GtoPdb: 2235] [UniProtKB: Q9H2K8] | ||||||||
ChEMBL | Inhibition of human wild type partial length TAOK3 (M1 to T316 residues) expressed in mammalian expression system by Kinomescan assay | B | 7.35 | pIC50 | 45 | nM | IC50 | J Med Chem (2022) 65: 12860-12882 [PMID:36111834] |
GtoPdb | - | - | 7.35 | pIC50 | 45 | nM | IC50 | J Med Chem (2022) 65: 12860-12882 [PMID:36111834] |
tau tubulin kinase 1/Tau-tubulin kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1926492] [GtoPdb: 2262] [UniProtKB: Q5TCY1] | ||||||||
ChEMBL | Inhibition of TTBK1 in human HEK293T cells incubated for 1 hrs by HTRF assay | B | 5.73 | pIC50 | 1850 | nM | IC50 | J Med Chem (2021) 64: 6358-6380 [PMID:33944571] |
GtoPdb | - | - | 6.7 | pIC50 | 199 | nM | IC50 | J Med Chem (2021) 64: 6358-6380 [PMID:33944571] |
ChEMBL | Inhibition of GST-tagged TTBK1 (1 to 421) (unknown origin) using DNA Topoisomerase 2-alpha-Thr1342 as substrate incubated for 15 mins followed by ATP addition and further incubated for 120 mins by TR-FRET assay | B | 6.7 | pIC50 | 199 | nM | IC50 | J Med Chem (2021) 64: 6358-6380 [PMID:33944571] |
testis specific serine kinase 1B/Testis-specific serine/threonine-protein kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6003] [GtoPdb: 2257] [UniProtKB: Q9BXA7] | ||||||||
ChEMBL | Inhibition of human wild type TSSK1 | B | 6.68 | pIC50 | 210 | nM | IC50 | J Med Chem (2022) 65: 12860-12882 [PMID:36111834] |
testis specific serine kinase 3/Testis-specific serine/threonine-protein kinase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3414416] [GtoPdb: 2259] [UniProtKB: Q96PN8] | ||||||||
ChEMBL | Inhibition of wild-type human full length TSSK3 (M1 to T268 residues) expressed in mammalian expression system by Kinomescan method | B | 7.04 | pIC50 | 91 | nM | IC50 | J Med Chem (2022) 65: 12860-12882 [PMID:36111834] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]